The WACC of Elliptic Laboratories AS (ELABS.OL) is 6.9%.
| Range | Selected | |
| Cost of equity | 5.90% - 8.00% | 6.95% |
| Tax rate | 17.80% - 19.20% | 18.50% |
| Cost of debt | 7.00% - 7.40% | 7.20% |
| WACC | 5.9% - 8.0% | 6.9% |
| Category | Low | High |
| Long-term bond rate | 3.3% | 3.8% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.5 | 0.6 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.90% | 8.00% |
| Tax rate | 17.80% | 19.20% |
| Debt/Equity ratio | 0.03 | 0.03 |
| Cost of debt | 7.00% | 7.40% |
| After-tax WACC | 5.9% | 8.0% |
| Selected WACC | 6.9% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for ELABS.OL:
cost_of_equity (6.95%) = risk_free_rate (3.55%) + equity_risk_premium (5.60%) * adjusted_beta (0.5) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.